An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome

Authors:

Abstract
S well as nonalcoholic steatohepatitis, fibrosis, dyslipidemia, and insulin resistance. AGTR1 is strongly expressed in adipose, liver, and arteries. The mechanism of this gain-of-function variant is unclear but may include adipose or endothelial dysfunction and immune activation. Despite previous unsuccessful clinical trials of angiotensin receptor blockers in nonalcoholic steatohepatitis, individuals with the rs5186A>C variant may have greater benefit from this therapy....

This publication has 35 references indexed in Scilit: